Pharma Poperinge: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pharma Poperinge
Largest movements
- Receivables within one year +€301,838
up €301,838 (+114%), from €265,187 to €567,025
of which Trade receivables: +€299,156
- Cash -€220,794
down €220,794 (-55.6%), from €396,796 to €176,002
mainly Contributions, distributions and other (-€888,000) and Receivables within one year (-€301,838)
- Stocks and contracts +€10,479
up €10,479 (+9.5%), from €110,389 to €120,868
- Tangible fixed assets -€9,853
down €9,853 (-23.8%), from €41,445 to €31,592
of which Furniture and vehicles: -€7,511
- Other debts +€747,957
up €747,957 (+17,199%), from €4,349 to €752,306
- Reserves -€705,015
down €705,015 (-94.8%), from €743,869 to €38,854
- Trade debts +€42,149
up €42,149 (+108%), from €38,981 to €81,130
- Gross operating margin -€78,966
down €78,966 (-20.9%), from €377,726 to €298,760
- Staff costs -€53,427
down €53,427 (-54.5%), from €98,066 to €44,639
- Financial income -€8,219
down €8,219 (-88.8%), from €9,257 to €1,038
- Taxes -€8,197
down €8,197 (-12.4%), from €66,081 to €57,885
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €816,717 | €898,903 | +€82,187 | +10.1% |
| Fixed assets | 21/28 | €42,037 | €32,084 | -€9,953 | -23.7% |
| Intangible fixed assets | 21 | €592 | €492 | -€100 | -16.9% |
| Tangible fixed assets | 22/27 | €41,445 | €31,592 | -€9,853 | -23.8% |
| Plant, machinery and equipment | 23 | €1,627 | €477 | -€1,150 | -70.7% |
| Furniture and vehicles | 24 | €32,764 | €25,253 | -€7,511 | -22.9% |
| Other tangible fixed assets | 26 | €7,054 | €5,862 | -€1,192 | -16.9% |
| Current assets | 29/58 | €774,680 | €866,820 | +€92,140 | +11.9% |
| Stocks and contracts in progress | 3 | €110,389 | €120,868 | +€10,479 | +9.5% |
| Stocks | 30/36 | €110,389 | €120,868 | +€10,479 | +9.5% |
| Amounts receivable within one year | 40/41 | €265,187 | €567,025 | +€301,838 | +114% |
| Trade receivables | 40 | €262,570 | €561,727 | +€299,156 | +114% |
| Other amounts receivable | 41 | €2,617 | €5,299 | +€2,682 | +102% |
| Current investments | 50/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €396,796 | €176,002 | -€220,794 | -55.6% |
| Deferred charges and accrued income | 490/1 | €2,307 | €2,924 | +€617 | +26.7% |
| Total equity and liabilities | 10/49 | €816,717 | €898,903 | +€82,187 | +10.1% |
| Equity | 10/15 | €748,869 | €43,854 | -€705,015 | -94.1% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €743,869 | €38,854 | -€705,015 | -94.8% |
| Distributable reserves | 133 | €743,869 | €38,854 | -€705,015 | -94.8% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €67,848 | €855,049 | +€787,202 | +1,160% |
| Amounts payable within one year | 42/48 | €67,836 | €855,037 | +€787,202 | +1,160% |
| Current portion of amounts payable after more than one year | 42 | €0 | - | = | |
| Trade debts | 44 | €38,981 | €81,130 | +€42,149 | +108% |
| Suppliers | 440/4 | €38,981 | €81,130 | +€42,149 | +108% |
| Advances received on contracts in progress | 46 | - | €517 | +€517 | |
| Taxes, remuneration and social security | 45 | €24,506 | €21,085 | -€3,421 | -14.0% |
| Taxes | 450/3 | €8,851 | €2,041 | -€6,810 | -76.9% |
| Remuneration and social security | 454/9 | €15,654 | €19,044 | +€3,390 | +21.7% |
| Other amounts payable | 47/48 | €4,349 | €752,306 | +€747,957 | +17,199% |
| Accrued charges and deferred income | 492/3 | €12 | €12 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €98,066 | €44,639 | -€53,427 | -54.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,416 | €12,963 | +€546 | +4.4% |
| Other operating charges | 640/8 | €1,094 | €1,128 | +€34 | +3.1% |
| Gross operating margin | 9900 | €377,726 | €298,760 | -€78,966 | -20.9% |
| Operating profit (loss) | 9901 | €266,151 | €240,031 | -€26,120 | -9.8% |
| Financial income | 75/76B | €9,257 | €1,038 | -€8,219 | -88.8% |
| Recurring financial income | 75 | €9,257 | €1,038 | -€8,219 | -88.8% |
| Financial charges | 65/66B | €664 | €199 | -€465 | -70.0% |
| Recurring financial charges | 65 | €664 | €199 | -€465 | -70.0% |
| Profit (loss) for the period before taxes | 9903 | €274,743 | €240,870 | -€33,873 | -12.3% |
| Income taxes | 67/77 | €66,081 | €57,885 | -€8,197 | -12.4% |
| Profit (loss) for the period | 9904 | €208,662 | €182,985 | -€25,677 | -12.3% |
| Profit (loss) for the period to be appropriated | 9905 | €208,662 | €182,985 | -€25,677 | -12.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.